Medinice S.A.
ISIN: PLMDNCE00016 | Ticker: ICE | LEI: 259400LGO9UDV1Y18Z11
Country: Poland
Medinice S.A. is a privately held company and is dedicated to develop new, innovative ideas for medical devices with its core focus in cardiology and Cardio Surgery. Company focuses on creating, developing and commercializing safe, minimally invasive medical technologies in the areas of cardiology and cardio surgery.
Medinice was formed in 2012 by two practising cardiology professionals who wished to bring their ideas to life. Currently Medinice is a public company listed on Warsaw Stock Exchange and has more than 12 products under its umbrella.
2 Hankiewicza St., 02-103 Warsaw – Poland
| Line item in (pln) | 01.01.2020 | 02.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|---|
| Assets | N/A | N/A | 20,919,000.00 | 49,115,000.00 | 41,898,000.00 |
| Noncurrent Assets | N/A | N/A | 7,509,000.00 | 16,251,000.00 | 19,957,000.00 |
| Property Plant And Equipment | N/A | N/A | 996,000.00 | 532,000.00 | 831,000.00 |
| Goodwill | N/A | N/A | 0.00 | 0.00 | 0.00 |
| Intangible Assets Other Than Goodwill | N/A | N/A | 6,488,000.00 | 10,489,000.00 | 13,534,000.00 |
| Investments In Subsidiaries Joint Ventures And Associates | N/A | N/A | 21,000.00 | 5,223,000.00 | 5,589,000.00 |
| Deferred Tax Assets | N/A | N/A | 4,000.00 | 7,000.00 | 3,000.00 |
| Current Assets | N/A | N/A | 13,410,000.00 | 32,864,000.00 | 21,941,000.00 |
| Trade And Other Current Receivables | N/A | N/A | 1,816,000.00 | 918,000.00 | 741,000.00 |
| Other Current Financial Assets | N/A | N/A | 22,000.00 | 0.00 | 0.00 |
| Other Current Nonfinancial Assets | N/A | N/A | 35,000.00 | 5,000.00 | 14,000.00 |
| Cash and cash equivalents | 5,513,000.00 | 11,542,000.00 | 11,537,000.00 | 31,941,000.00 | 21,186,000.00 |
| Equity And Liabilities | N/A | N/A | 20,919,000.00 | 49,115,000.00 | 41,898,000.00 |
| Equity | 8,182,000.00 | 16,940,000.00 | 16,980,000.00 | 40,512,000.00 | 37,127,000.00 |
| Issued Capital | N/A | N/A | 536,000.00 | 619,000.00 | 627,000.00 |
| Retained Earnings | N/A | N/A | -8,206,000.00 | -11,135,000.00 | -16,060,000.00 |
| Share Premium | N/A | N/A | 24,002,000.00 | 47,420,000.00 | 47,420,000.00 |
| Reserve Of Sharebased Payments | N/A | N/A | 651,000.00 | 3,608,000.00 | 5,140,000.00 |
| Equity Attributable To Owners Of Parent | N/A | N/A | 16,983,000.00 | 40,512,000.00 | 37,127,000.00 |
| Noncontrolling Interests | N/A | N/A | -3,000.00 | 0.00 | 0.00 |
| Liabilities | N/A | N/A | 3,939,000.00 | 8,603,000.00 | 4,771,000.00 |
| Noncurrent Liabilities | N/A | N/A | 2,555,000.00 | 7,442,000.00 | 3,758,000.00 |
| Noncurrent Government Grants | N/A | N/A | 2,315,000.00 | 7,162,000.00 | 3,467,000.00 |
| Deferred Tax Liabilities | N/A | N/A | 4,000.00 | 8,000.00 | 3,000.00 |
| Noncurrent Portion Of Noncurrent Loans Received | N/A | N/A | 0.00 | 0.00 | 0.00 |
| Current Liabilities | N/A | N/A | 1,384,000.00 | 1,161,000.00 | 1,013,000.00 |
| Current Provisions | N/A | N/A | 49,000.00 | 90,000.00 | 94,000.00 |
| Trade And Other Current Payables | N/A | N/A | 414,000.00 | 379,000.00 | 625,000.00 |
| Other Current Financial Liabilities | N/A | N/A | 570,000.00 | 304,000.00 | 88,000.00 |
| Current Loans Received And Current Portion Of Noncurrent Loans Received | N/A | N/A | 351,000.00 | 388,000.00 | 206,000.00 |
| Line item in (pln) | 01.12.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|---|
| Revenue | 372,000.00 | 285,000.00 | 246,000.00 |
| Raw Materials And Consumables Used | 122,000.00 | 74,000.00 | 111,000.00 |
| Services Expense | 1,520,000.00 | 1,370,000.00 | 1,253,000.00 |
| Employee Benefits Expense | 754,000.00 | 1,810,000.00 | 2,917,000.00 |
| Depreciation And Amortisation Expense | 362,000.00 | 362,000.00 | 314,000.00 |
| Tax Expense Other Than Income Tax Expense | 37,000.00 | 68,000.00 | 30,000.00 |
| Other Expense By Nature | 39,000.00 | 101,000.00 | 258,000.00 |
| Profit Loss From Operating Activities | -2,523,000.00 | -3,285,000.00 | -4,999,000.00 |
| Finance Income | 1,000.00 | 903,000.00 | 415,000.00 |
| Finance Costs | 149,000.00 | 59,000.00 | 75,000.00 |
| Impairment Loss Impairment Gain And Reversal Of Impairment Loss Determined In Accordance With I F R S9 | 351,000.00 | 435,000.00 | 266,000.00 |
| Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method | 0.00 | 0.00 | 0.00 |
| Profit Loss Before Tax | -3,022,000.00 | -2,876,000.00 | -4,925,000.00 |
| Income Tax Expense Continuing Operations | 0.00 | 10,000.00 | 0.00 |
| Profit Loss From Continuing Operations | -3,022,000.00 | -2,886,000.00 | -4,925,000.00 |
| Profit Loss From Discontinued Operations | 0.00 | 0.00 | 0.00 |
| Profit (loss) | -3,022,000.00 | -2,886,000.00 | -4,925,000.00 |
| Profit Loss Attributable To Owners Of Parent | -3,021,000.00 | -2,883,000.00 | -4,925,000.00 |
| Profit Loss Attributable To Noncontrolling Interests | -1,000.00 | 3,000.00 | 0.00 |
| Line item in (pln) | 01.01.2020 | 02.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|---|
| Profit (loss) | N/A | N/A | -3,022,000.00 | -2,886,000.00 | -4,925,000.00 |
| Adjustments For Finance Costs | N/A | N/A | 134,000.00 | 0.00 | 0.00 |
| Adjustments For Depreciation And Amortisation Expense | N/A | N/A | 362,000.00 | 362,000.00 | 314,000.00 |
| Adjustments For Provisions | N/A | N/A | -16,000.00 | -61,000.00 | 1,000.00 |
| Adjustments For Unrealised Foreign Exchange Losses Gains | N/A | N/A | 0.00 | -24,000.00 | -20,000.00 |
| Adjustments For Sharebased Payments | N/A | N/A | 348,000.00 | 798,000.00 | 1,532,000.00 |
| Other Adjustments To Reconcile Profit Loss | N/A | N/A | -180,000.00 | 137,000.00 | -1,000.00 |
| Interest Paid Classified As Operating Activities | N/A | N/A | 101,000.00 | 0.00 | N/A |
| Cash Flows From Used In Operating Activities | N/A | N/A | -3,264,000.00 | -1,706,000.00 | -2,788,000.00 |
| Other Cash Receipts From Sales Of Interests In Joint Ventures Classified As Investing Activities | N/A | N/A | 500,000.00 | 690,000.00 | 0.00 |
| Other Cash Payments To Acquire Interests In Joint Ventures Classified As Investing Activities | N/A | N/A | 0.00 | 838,000.00 | 0.00 |
| Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities | N/A | N/A | 0.00 | 786,000.00 | 0.00 |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | N/A | N/A | 82,000.00 | 314,000.00 | 448,000.00 |
| Purchase Of Intangible Assets Classified As Investing Activities | N/A | N/A | 2,888,000.00 | 4,039,000.00 | 3,068,000.00 |
| Cash Advances And Loans Made To Other Parties Classified As Investing Activities | N/A | N/A | 0.00 | 0.00 | 600,000.00 |
| Cash Flows From Used In Investing Activities | N/A | N/A | -2,489,000.00 | -6,626,000.00 | -4,116,000.00 |
| Proceeds From Issuing Shares | N/A | N/A | 12,200,000.00 | 25,837,000.00 | 8,000.00 |
| Proceeds From Borrowings Classified As Financing Activities | N/A | N/A | 0.00 | 0.00 | 0.00 |
| Repayments Of Borrowings Classified As Financing Activities | N/A | N/A | 0.00 | 0.00 | 350,000.00 |
| Payments Of Lease Liabilities Classified As Financing Activities | N/A | N/A | 67,000.00 | 78,000.00 | 82,000.00 |
| Proceeds From Government Grants Classified As Financing Activities | N/A | N/A | 1,239,000.00 | 6,207,000.00 | 765,000.00 |
| Interest Paid Classified As Financing Activities | N/A | N/A | 21,000.00 | 33,000.00 | 17,000.00 |
| Cash Flows From Used In Financing Activities | N/A | N/A | 11,777,000.00 | 28,730,000.00 | -3,852,000.00 |
| Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | N/A | N/A | 6,024,000.00 | 20,398,000.00 | -10,756,000.00 |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | N/A | N/A | 0.00 | 0.00 | 0.00 |
| Increase (decrease) in cash and cash equivalents after effect of exchange rate changes | N/A | N/A | 6,024,000.00 | 20,398,000.00 | -10,756,000.00 |
| Cash and cash equivalents | 5,513,000.00 | 11,542,000.00 | 11,537,000.00 | 31,941,000.00 | 21,186,000.00 |
Please note that some sums might not add up.
PLMDNCE00016
LEI259400LGO9UDV1Y18Z11
SectorHealth Care Equipment & Services
IndustryHealth Care Equipment & Supplies
Sub-IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.